Reseda Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
as on 25-07-2024
- Paid Up Capital ₹ 2.73 M
as on 25-07-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.00 M
as on 25-07-2024
- Revenue -10.19%
(FY 2023)
- Profit 21.18%
(FY 2023)
- Ebitda 21.07%
(FY 2023)
- Net Worth -172.11%
(FY 2023)
- Total Assets -19.64%
(FY 2023)
About Reseda Lifesciences
The Corporate was formerly known as Nettare Bio Labs Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 2.73 M.
The company currently has active open charges totaling ₹1.30 Cr.
Pamidipati Gayatri, Lalitha Pamidipati, and Saligrama Kumar serve as directors at the Company.
- CIN/LLPIN
U73200KA2017PTC105451
- Company No.
105451
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore South, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Reseda Lifesciences Private Limited offer?
Reseda Lifesciences Private Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Kitchen Cleaners, Mosquito & Insect Repellent, Mosquito Repellent, Floor Cleaner.
Who are the key members and board of directors at Reseda Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pamidipati Gayatri  | Managing Director | 09-Aug-2017 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lalitha Pamidipati | Director | 27-Feb-2019 | Current |
| Saligrama Kumar | Director | 06-Mar-2019 | Current |
Financial Performance and Corporate Structure Insights of Reseda Lifesciences.
Reseda Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.19% decrease. The company also saw a substantial improvement in profitability, with a 21.18% increase in profit. The company's net worth observed a substantial decline by a decrease of 172.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reseda Lifesciences?
In 2023, Reseda Lifesciences had a promoter holding of 93.77% and a public holding of 6.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ethnys Foundation
Active 4 years 11 monthsPamidipati Gayatri and Lalitha Pamidipati are mutual person
Helsi Green Equipment Manufacturers Private Limited
Active 1 year 2 monthsPamidipati Gayatri is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 24 Dec 2021 | ₹5.00 M | Open |
Axis Bank Limited Creation Date: 29 Oct 2020 | ₹8.00 M | Open |
How Many Employees Work at Reseda Lifesciences?
Unlock and access historical data on people associated with Reseda Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reseda Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reseda Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
